来那度胺联合硼替佐米和地塞米松诱导治疗初诊多发性骨髓瘤患者的疗效和安全性

OBJECTIVE: This study aimed to evaluate the efficacy and safety of lenalidomide combined with bortezomib and dexamethasone（VRD）in the treatment of newly diagnosed multiple myeloma（MM）. METHODS: A total of 150 newly diagnosed patients with MM diagnosed in The First Affiliated Hospital of Soochow Univ...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593008/
https://www.ncbi.nlm.nih.gov/pubmed/36709150
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.08.007

Ejemplares similares

Ejemplares similares